Avalanche Biotechnologies Secures $55 Million in Oversubscribed Series B Financing

Funding Rounds

▤ Summary

Avalanche Biotechnologies secured $55 million in an oversubscribed Series B financing round. The funding likely supports the company’s continued development and commercialization efforts in biotechnology. This type of capital event can signal hiring, platform expansion, and increased vendor activity. Software vendors serving life sciences organizations may find opportunities around research, clinical, data, and operational systems.

$ Funding

$
Amount $55.0M Total raised
□
Date April 22, 2014 Announcement date
◎
Investors - Lead investors
▥
Company avalanchebiotech.com Funded company

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies